Abstract
Introduction
Cancer patients experience multiple concurrent symptoms. This exploratory analysis assessed symptom burden among patients undergoing chemotherapy for breast cancer to identify distinct subgroups of patients who experience differential symptom burden and assessed whether the patient subgroups were associated with deleterious quality of life (QOL) outcomes.
Materials and methods
Women (N = 133) with stage I and II breast cancer undergoing adjuvant chemotherapy after primary surgery were evaluated at baseline and at the end of chemotherapy using the Memorial Symptom Assessment Scale (MSAS) and the SF-36 QOL questionnaire. Post treatment MSAS symptoms were included in hierarchical cluster analysis. Two patient subgroups were identified that corresponded to a high-symptom prevalence group and a low-symptom group.
Results and discussion
No marked, statistically significant differences were found between groups on demographic, symptoms, QOL, or treatment variables at baseline. Patients in the high-symptom cluster were more likely to have stage I disease (p < 0.05). The two groups of patients showed significant differences in end-of-treatment symptoms and QOL scores (p < 0.05). The high-symptom burden group was more likely to report greater symptom prevalence and poorer QOL.
Conclusions
Future research needs to examine why these differences occur despite similarities in treatment and how symptom burden can be reduced for the high-symptom prevalence group.
Similar content being viewed by others
References
Jacobsen PB (2004) Assessment of fatigue in cancer patients. J Natl Cancer Inst Monographs 32:93–97
Paice JA (2004) Assessment of symptom clusters in people with cancer. J Natl Cancer Inst Monographs 32:98–102
Chang VT, Hwang SS, Kasimis B, Thaler HT (2004) Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Investig 22(4):526–536
Bender CM, Ergyn FS, Rosenzweig MQ, Cohen SM, Sereika SM (2005) Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nurs 28(3):219–225
Chen ML, Tseng HCS (2006) Symptom clusters in cancer patients. Support Care Cancer 14(8):25–30
Chen ML, Tseng HH (2005) Identification and verification of symptom clusters in cancer patients. J Support Oncol 3(4):28–29
Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer 14(8):831–836
Chang VT, Hwang SS, Feuerman M, Kasimis BS (2000) Symptom and quality of life survey of medical oncology patients at a veteran's affairs medical center: a role for symptom assessment. Cancer 88(5):1175–1183
Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN (2006) Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage 31(1):85–95
Beck SL (2004) Symptom clusters: impediments and suggestions for solutions. J Natl Cancer Inst Monographs 32:137–138
Shapiro DE, Rodrigue JR, Boggs SR, Robinson ME (1994) Cluster analysis of the medical coping modes questionnaire: evidence for coping with cancer styles. J Psychosom Res 38(2):151–159
Shapiro DE, Boggs SR, Rodrigue JR, Urry HL, Algina JJ, Hellman R, Ewen F (1997) Stage II breast cancer: differences between four coping patterns in side effects during adjuvant chemotherapy. J Psychosom Res 43(2):143–157
Hack TF, Degner LF (1999) Coping with breast cancer: a cluster analytic approach. Breast Cancer Res Treat 54(3):185–194
Nagel GC, Schmidt S, Strauss BM, Katenkamp D (2001) Quality of life in breast cancer patients: a cluster analytic approach. Empirically derived subgroups of the EORTC-QLQ BR 23—a clinically oriented assessment. Breast Cancer Res Treat 68(1):75–87
Trask PC, Griffith KA (2004) The identification of empirically derived cancer patient subgroups using psychosocial variables. J Psychosom Res 57(3):287–295
Miaskowski C, Cooper B, Paul S, Dodd M, Lee K, Aouizerat B, West C, Cho M, Bank A (2006) Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum 33(5):79–89
Miaskowski C, Dodd M, Lee K (2004) Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monographs 32:17–21
National Institutes of Health (2002) NIH State-of-the-Science Statement on symptom management in cancer: pain, depression, and fatigue. NIH Consens State Sci Statements 19(4):1–29
Turk DC (1990) Customizing treatment for chronic pain patients: who, what, and why. Clin J Pain 6(4):255–270
Turk DC, Rudy TE (1990) The robustness of an empirically derived taxonomy of chronic pain patients. Pain 43(1):27–35
Sorkin BA, Rudy TE, Hanlon RB, Turk DC, Stieg RL (1990) Chronic pain in old and young patients: differences appear less important than similarities. J Gerontol 45(2):64–68
Turk DC, Rudy TE (1988) Toward an empirically derived taxonomy of chronic pain patients: integration of psychological assessment data. J Consult Clin Psychol 56(2):233–238
Jamison RN, Rudy TE, Penzien DB, Mosley TH Jr (1994) Cognitive-behavioral classifications of chronic pain: replication and extension of empirically derived patient profiles. Pain 57(3):277–292
Donovan KA, Small BJ, Andrykowski MA, Munster P, Jacobsen PB (2007) Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychol 26(4):464–472
Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Coyle N (1994) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3(3):183–189
Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326–1336
Brazier JE, Harper R, Jones NM, O, Cathain A, Thomas KJ, Usherwood T, Westlake L (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305(6846):160–164
McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD (1994) The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32(1):40–66
McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31(3):247–263
Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33(4):264–279
McHorney CA, Ware JE Jr (1995) Construction and validation of an alternate form general mental health scale for the Medical Outcomes Study Short-Form 36-Item Health Survey. Med Care 33(1):15–28
Anderberg MR (1973) Cluster analysis for applications. Academic, New York
Sarle WS (1983) Cubic clustering criterion. SAS technical report A-108. SAS Institute, Cary, NC
Cohen J (1988) Statistical power analysis for the behavioral sciences. Erlbaum, Mahwah, NJ
Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28(4):270–282
Sloan JA, McLeod D, Sargent D, Zhao X, Fuchs C, Ramanathan R, Williamson S, Findlay B, Morton R, Goldberg RM (2004) Preliminary evidence of relationship between genetic markers and oncology patient quality of life (QOL). J Clin Oncol 22(14S):5
Acknowledgements
This study was supported in part by research grants from the National Institutes of Health, National Cancer Institute (Parent grant #: 3 R01 CA082822-05 and research supplement #: 3 R01 CA082822-05S1).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gwede, C.K., Small, B.J., Munster, P.N. et al. Exploring the differential experience of breast cancer treatment-related symptoms: a cluster analytic approach. Support Care Cancer 16, 925–933 (2008). https://doi.org/10.1007/s00520-007-0364-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-007-0364-2